Leukemia, Biphenotypic, Acute
"Leukemia, Biphenotypic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from MULTIPOTENT STEM CELLS.
| Descriptor ID |
D015456
|
| MeSH Number(s) |
C04.557.337.428.100 C15.604.515.560.100 C20.683.515.528.100
|
| Concept/Terms |
Leukemia, Biphenotypic, Acute- Leukemia, Biphenotypic, Acute
- B- and T-Cell Acute Lymphoblastic Leukemia
- B- and T-Cell Leukemia, Acute
- Leukemia, Lymphocytic, Acute, Mixed Cell
- Leukemia, Lymphocytic, Acute, Mixed-Cell
- Leukemia, Mixed, B and T Cell
- Leukemia, Mixed, B- and T-Cell
- Leukemia, Mixed-Cell
- Leukemia, Mixed Cell
- Leukemias, Mixed-Cell
- Mixed-Cell Leukemia
- Mixed-Cell Leukemias
- Lymphocytic Leukemia, Acute, B and T Cell
- Lymphocytic Leukemia, Acute, B- and T-Cell
- Acute Biphenotypic Leukemia
- Acute Biphenotypic Leukemias
- Biphenotypic Leukemia, Acute
- Biphenotypic Leukemias, Acute
- Leukemia, Acute Biphenotypic
- Leukemias, Acute Biphenotypic
- Biphenotypic Acute Leukemia
- Acute Leukemia, Biphenotypic
- Acute Leukemias, Biphenotypic
- Biphenotypic Acute Leukemias
- Leukemia, Biphenotypic Acute
- Leukemias, Biphenotypic Acute
- Hybrid Acute Leukemias
- Acute Leukemia, Hybrid
- Acute Leukemias, Hybrid
- Hybrid Acute Leukemia
- Leukemia, Hybrid Acute
- Leukemias, Hybrid Acute
- Mixed-Lineage Acute Leukemias
- Acute Leukemia, Mixed-Lineage
- Acute Leukemias, Mixed-Lineage
- Leukemia, Mixed-Lineage Acute
- Leukemias, Mixed-Lineage Acute
- Mixed Lineage Acute Leukemias
- Mixed-Lineage Acute Leukemia
- B and T Cell Acute Lymphoblastic Leukemia
- B and T Cell Leukemia, Acute
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Biphenotypic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Biphenotypic, Acute".
This graph shows the total number of publications written about "Leukemia, Biphenotypic, Acute" by people in this website by year, and whether "Leukemia, Biphenotypic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Biphenotypic, Acute" by people in Profiles.
-
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. Cancer. 2020 02 01; 126(3):593-601.
-
Patient with mixed-phenotype acute leukemia with CBFB rearrangement. Leuk Lymphoma. 2019 11; 60(11):2829-2831.
-
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Am J Hematol. 2018 11; 93(11):1358-1367.
-
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun. 2018 07 10; 9(1):2670.
-
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018 07 19; 132(3):264-276.
-
An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Ann Hematol. 2018 Jun; 97(6):945-953.
-
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports. J Med Case Rep. 2016 Jul 28; 10:209.
-
Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol. 2016 08; 44(8):740-4.
-
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. Am J Hematol. 2016 06; 91(6):647-8.
-
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. Biol Blood Marrow Transplant. 2015 Jan; 21(1):55-9.